CMS has released a proposed rule on value-based purchasing, which involves paying hospitals for performance on quality measures, according to a release by CMS. Currently, CMS pays hospitals simply for ...

CMS recently issued final rules for its value-based purchasing program for hospitals. Beginning in fiscal year 2013, which starts on Oct. 1, 2012, CMS will offer hospitals an incentive payment for ...

In October 2012, the Centers for Medicare and Medicaid Services (CMS) will launch value-based purchasing, which will impact discharge payment structures for all short-term acute care hospitals. To ...

Medicare’s value-based programs are penalizing inpatient hospitals for community-level health equity factors that impact outcomes but are largely out of hospitals’ control, according to a recent ...

More than 1,800 hospitals will see payments from the federal government rise in 2016 due to improvements in quality under the Centers for Medicare and Medicaid Services value-based purchasing program, ...

CMS published its FY 2025 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule on August 1, 2024. Under this final rule, CMS is implementing several changes to its Hospital ...

Medicare’s upcoming health equity adjustment in the Hospital Value-Based Purchasing (HVBP) program will reduce disproportionate penalization among safety net hospitals and those serving high ...

A new audit-like process designed to test the validity of nursing homes’ quality data is being pushed back until early 2026. The Centers for Medicare & Medicaid Services’ Skilled Nursing Facility Data ...

While some nursing homes have earned incentive pay for reducing their hospital readmissions, the decade-old program that pays for those bonuses has not led to any widespread improvements, a ...

A CMS proposal to base future hospital payments partly on hospital-acquired conditions as part of its value-based purchasing program raises “serious concerns” because HACs are already measured for ...

Health may be priceless, but healthcare is not. With medical costs on the rise, insurance companies and government payers are increasingly asking pharmaceutical companies and device manufacturers to ...